IKNA - Ikena Oncology - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Ikena Oncology's activity chart (see below) currently has 29 price targets and 23 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 36.43% with an average time for these price targets to be met of 212.14 days.

Most recent stock forecast was given by from WEDBUSH on 25-Jul-2025. First documented stock forecast 20-Apr-2021.

Best performing analysts who are covering IKNA - Ikena Oncology:

Andres Maldonado Robert Burns Judah Frommer Evan Seigerman David Nierengarten

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 25-Jul-2025

$23

$5.84 (34.03%)

$8

1 years 2 months 28 days ago
(25-Jul-2025)

0/5 (0%)

$5.84 (34.03%)

Buy Since 24-May-2023

$4

1 years 11 months 12 days ago
(11-Nov-2024)

2/6 (33.33%)

$-15.68 (-79.67%)

132

Buy Since 13-May-2022

$156

$138.84 (809.09%)

$13

3 years 5 months 7 days ago
(16-May-2023)

4/5 (80%)

$82.08 (111.04%)

503

Buy Since 23-Dec-2021

$22

$4.84 (28.21%)

$22

3 years 7 months 6 days ago
(17-Mar-2023)

3/4 (75%)

$-27.32 (-55.39%)

265

Buy Since 20-Apr-2021

$27

$9.84 (57.34%)

5 years 2 months 10 days ago
(13-Aug-2021)

1/3 (33.33%)

$-102.36 (-79.13%)

453

Show more analysts

Please expand the browser size to see the chart

What is IKNA (Ikena Oncology) average time for price targets to be met?

On average it took 212 days for the stock forecasts to be reached, with an average price target met ratio of 36.43%.

Which analyst most recently updated their price target on IKNA (Ikena Oncology)?

Which analyst has the most public recommendations on IKNA (Ikena Oncology)?

has 0 price targets and 0 ratings on IKNA

Which analyst is the currently most bullish on IKNA (Ikena Oncology)?

Judah Frommer with the highest potential upside of $138.84

Which analyst is the currently most reserved on IKNA (Ikena Oncology)?

Andres Maldonado with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?